The objective was to investigate the relationship between the presence of dierent types of antinuclear antibodies (ANA) in patients with systemic sclerosis (SSc) and the presence of clinical features. Sera from 230 patients with SSc were tested for the presence of ANA, including anticentromere antibodies (ab), antitopoisomerase I ab, anti-U1 RNP ab and antinucleolar ab, including anti-Th RNP, anti-U3 RNP and anti-U17 RNP. Clinical features were registered prospectively in a clinical database. Eighty-two per cent of the patients were women. The median age was 58 yr (45±67, quartiles) and median age at disease onset was 44 (30±55) yr. ANA were found in 86% of the patients (anticentromere: 34%; antitopoisomerase I: 14%; anti-U1 RNP: 6.5%; antinucleolar total: 16%; anti-Th RNP: 2.2%; anti-U3 RNP: 3.5%; anti-U17 RNP: 0%). Anticentromere ab were found to be related to a high prevalence of calcinosis, telangiectasia, digital ulcers, acrosclerosis, primary biliary cirrhosis, isolated reduction of pulmonary diusing capacity, and a low prevalence of radiological evidence of pulmonary ®brosis. Antitopoisomerase I ab were associated with a high prevalence of digital joint deformity, distal osteolysis, radiological signs of pulmonary ®brosis, a low prevalence of calcinosis and late onset of disease. Anti-U1 RNP ab were related to a high prevalence of arthritis and myositis, a low prevalence of calcinosis, and early disease onset. The presence of antinucleolar ab, including anti-U3 RNP and anti-Th RNP, was not signi®cantly related to any particular clinical features in this study; possibly due to the small number of patients with these ab. The presence of anticentromere, antitopoisomerase I and anti-U1 RNP ab in the serum was also found to have previously described clinical correlations in a group of Danish SSc patients.
SYSTEMIC sclerosis (SSc) is an autoimmune disease characterized by ®brotic changes in the skin, blood vessels and various internal organs. The disease has a wide spectrum of presentation and clinical course, but may be classi®ed according to the extent of cutaneous involvement. Patients with diuse SSc have symmetrical skin thickening of the trunk, face and the distal, and often proximal, extremities, whereas patients with limited SSc most often have involvement only of the distal extremities and face. Patients with diuse SSc are at greater risk of developing rapid progression of both skin thickening and some types of visceral involvement than those with limited skin involvement [1] .
Serum antinuclear antibodies (ANA) are a prominent feature of SSc with prevalences varying from 89 to 95%, depending on the methods used [2, 3] . Several speci®cities of ANA have been found to identify subsets of SSc patients, as for example antitopoisomerase I (antitopo I) antibodies (ab), which tend to identify patients with diuse cutaneous disease and restrictive pulmonary disease, and anticentromere ab, which are most often found in patients with limited cutaneous disease, calcinosis, telangiectasia and progressive deterioration of lung diusing capacity in patients without restrictive lung disease [2, 4, 5] . Racial factors may in¯uence the prevalence of some types of ANA in patients with SSc [6] .
Antinucleolar ab have been identi®ed in 15±20% of patients with SSc [4] . Recently, several nucleolar targets for these ab have been identi®ed, which may also serve as markers of the clinical course in SSc [3] .
In the present study, we have investigated the frequencies and clinical associations of several types of SSc-related ANA in sera from 230 Danish patients with a de®nite clinical picture of SSc.
PATIENTS AND METHODS

Patients and serum samples
Two-hundred and thirty consecutive patients, who ful®lled the American Rheumatism Association (ARA) preliminary criteria for the classi®cation of SSc [7] , were included in a prospective study. The patients were referred from all parts of Denmark, and they were seen at the Department of Dermatology, State University Hospital, and the Department of Rheumatology, Hvidovre Hospital, from 1980 to 1993. All patients were seen by at least one of the authors and evaluated using a standard clinical protocol. A serum sample was obtained from each patient at the ®rst visit and stored at ±208C until studied.
Clinical features
Medical history, and physical and laboratory ®nd-ings were entered consecutively into a cumulative database. Disease onset was de®ned as the time of the ®rst SSc-related symptom. The patients were classi®ed according to the extent of skin thickening as suggested by Masi [8] : (1) digital only: skin involvement located only distal to the metacarpophalangeal or metatarsophalangeal joints (type I involvement); (2) proximal extremity: skin involvement of the proximal extremities or the face, but not the trunk (type II involvement); (3) truncal: skin involvement of the thorax or abdomen (type III involvement).
The de®nitions of organ involvement were as follows: (a) Raynaud's phenomenon: intermittent attacks of digital pallor or cyanosis; (b) calcinosis: radiographically identi®ed s.c. calci®cations; (c) chronic digital ischaemia: digital ulcers or scars; (d) telangiectasia: cutaneous vascular lesions formed by dilation of a group of small blood vessels; (e) oesophageal hypomotility: distal oesophageal hypomotility judged by radiological examination of oesophagus and/or oesophageal manometry; (f ) pulmonary ®brosis: bibasilar interstitial ®brosis on chest radiograph; (g) distal osteolysis: radiographically identi®ed loss of bony substance of the digits; (h) SSc joint deformity: digital contractures; (i) arthritis: in¯ammatory arthropathy with swelling of two or more joints; ( j) skeletal muscle involvement: muscle weakness and elevated creatine phosphokinase, myopathic electromyogram and/or characteristic biopsy ®ndings; (k) serositis: pericarditis or pleurisy judged by radiography or ultrasound examination; (l) cardiac involvement: clinical or electrocardiographic abnormalities in the absence of other causes; (m) renal involvement: renal insuciency and/or accelerated arterial hypertension in the absence of other causes; (n) primary biliary cirrhosis (PBC): abnormal and cholestatic liver biochemistry, raised serum IgM, and antimitochondrial ab; (o) sicca complex was de®ned as keratoconjunctivitis sicca by Schirmer's test, break-up time or Rose±Bengal dye, and xerostomia by sialometry, salivary gland biopsy or sialoscintigraphy.
Pulmonary function tests
Pulmonary function tests (PFT) were carried out by means of computerized Jaeger lung function equipment. PFT included measurement of slow inspiratory vital capacity (VC) and the diusing capacity of CO (DLco). VC and DLco were considered abnormal if the values were <80% of the predicted values according to Quanjer [9] .
Serological tests
The serological tests comprised the determination of IgG ANA by an indirect immuno¯uorescence technique (IIF) using commercially prepared slides of monolayer HEp-2 cells (ImmunoConcepts, Sacramento, CA, USA) as substrate and¯uorescein isothiocyanate (FITC)-labelled rabbit immunoglobulins against human Fcg (Dako, Denmark). Sera were screened at a dilution of 1:40, and positive reactions were categorized according to the nuclear immuno¯uorescence pattern [10] . Titres were determined by 2-fold end point titration. Anticentromere ab were reported without further subspeci®city testing, whereas homogeneous or speckled nuclear patterns were subsequently studied for the presence of antitopo I and anti-U1 RNP ab. Antitopo I ab were detected by double immunodiusion against a thymus±spleen extract (Auto I.D., ImmunoConcepts, Sacramento, CA, USA) and reference sera. Anti-U1 RNP ab were detected by passive haemagglutination technique [11] . The presence of the antinucleolar ab anti-Th RNP, anti-U3 RNP and anti-U17 RNP was determined using radioactively labelled antisense riboprobes [12] . This method has the advantage of very speci®c antisense labelling of the immunoprecipitated RNA, use of little radioactive isotope only in the last phase of the procedure, and a comparable sensitivity to radioimmunoprecipitation. Antimitochondrial ab were determined by an enzyme-linked immunosorbent assay using submitochondrial particles as substrate [13] .
Statistical analyses
Comparisons of categorical variables were performed using the w 2 test with Mantel±Haenszel correction when appropriate. Relative risks were calculated using the presence of the antibodies studied as an exposure factor. Median values and quartiles were stated, and non-parametric statistics used for continuous variables that were not normally distributed.
RESULTS
Patients
The 230 patients consisted of 82% women. The median age was 59 yr (range 16±84 yr, quartiles 46± 68 yr). All patients, except one, who was Asiatic, were of Caucasian origin.
The median age at disease onset was 44 yr (range 7±83 yr, quartiles 30±55 yr) and median disease duration was 11 yr (range 0±53 yr, quartiles 5±19 yr). The types of skin involvement in the patients were digital only (12%), proximal extremity (62%) and truncal (26%).
Serological ®ndings
One hundred and ninety-six (85%) patients had ANA. As seen in Table I , 79 (34%) had anticentromere ab, 31 (13%) had antitopo I ab and 15 (6.5%) had anti-U1 RNP ab. Thirty-six patients (16%) had a nucleolar pattern by IIF on HEp-2 cells, and among those 8 (3.5%) had anti-U3 RNP, 5 (2.2%) had anti-Th RNP and none had anti-U17 RNP.
No patient with anticentromere ab had other ANA speci®cities. However, the presence of antimitochondrial ab (n = 14) was highly related to the presence of anticentromere ab. These two ab appeared together in 13 patients, and the relative risk of having antimitochondrial ab in the presence of anticentromere ab was 25 (P < 0.00001).
Of the 43 patients who had a homogeneous and/or ®ne speckled nucleoplasmic pattern, antitopo I ab were detected in 31 patients. Seven of the 31 patients with antitopo I ab also had a nucleolar pattern on IIF, but in none of them was a speci®c antinucleolar subspeci®city identi®ed. neg, negative; pos, positive. a, P < 0.05; b, P < 0.01; c, P < 0.001; d, P < 0.0001 when comparing patients with or without a particular antinuclear antibody. A, P < 0.05; B, P < 0.01; C, P < 0.001; D, P < 0.0001 when comparing patients with a particular antinuclear antibody to patients without any antinuclear antibodies. For continuous variables, median values and quartiles are given. Tables II and III provide an overview of the demographic and clinical features of the patients strati®ed according to the type of ANA found. Tables IIIa  and b show the associations between serological and clinical ®ndings in this material.
Relationships between serological and clinical ®ndings
The presence of anticentromere ab indicated a female preponderance, long disease duration, limited cutaneous disease, and a high frequency of Raynaud's phenomenon, calcinosis, digital ulcers, scars and telangiectasia. All patients with concomitant primary biliary cirrhosis (n = 6) had anticentromere ab. The sicca complex was also found more often in patients with anticentromere ab than in those without this ab. The presence of anticentromere ab was related to a low frequency of radiographically identi®ed pulmonary ®brosis and skeletal muscle involvement.
Patients with antitopo I ab were relatively old at disease onset. The presence of antitopo I ab related to a high frequency of pulmonary ®brosis, distal osteolysis and digital joint deformities, and a low frequency of calcinosis.
All patients with anti-U1 RNP ab had limited cutaneous involvement. Anti-U1 RNP ab were closely related to sclerodactyly only, skeletal muscle involvement and arthritis, but inversely related to the presence of joint deformities. This group of patients was signi®cantly younger at disease onset than patients without this ab.
Anti-Th ab were found only in patients with extremity involvement, but due to the small number this was not statistically signi®cant. The presence of anti-Th RNP ab was inversely related to joint deformities. No clinical correlations were found for anti-U3 RNP ab within this group of patients.
Thirty-four patients did not have any ANA. These patients were characterized by having a signi®cantly lower occurrence of the following clinical features: distal osteolysis, calcinosis, telangiectasia and Raynaud's phenomenon. They tended to have more serositis and cardiac involvement, but this was not statistically signi®cant.
Relationships between subsets of SSc and serological ®ndings
The prevalences of antitopo I ab and anticentromere ab in patients with truncal involvement were 21 and 19%, respectively. For the remaining patients, the prevalences were 9 and 42%, respectively.
Patients with limited cutaneous involvement, s.c. calcinosis, Raynaud's phenomenon, oesophageal hypomotility, sclerodactyly and cutaneous telangiectasia form a subset: the CREST syndrome. Thirty®ve patients had the CREST syndrome and 63% of them had circulating anticentromere ab vs 29% of the patients without the syndrome (P = 0.0001).
Six SSc patients had concomitant PBC. All but one had type I or II cutaneous involvement, and none had pulmonary ®brosis. They all had circulating anticentromere ab and antimitochondrial ab.
Eight patients had a complete sicca complex, and six of them also had anticentromere ab. In this material, separate keratoconjunctivitis sicca and xerostomia were not related to anticentromere ab. Two patients had PBC, anticentromere ab, CREST syndrome and keratoconjunctivitis sicca (PACK syndrome).
Fifty-one per cent of the patients with reduced DLco, but normal VC and chest radiograph, had circulating anticentromere ab vs 28% of the patients without this type of pulmonary involvement (P = 0.005). None of the other ANA speci®cities investigated were related to an isolated reduction of pulmonary diusing capacity. Sixteen patients had a combination of type III cutaneous involvement and radiographically identi®ed pulmonary ®brosis, seven of whom (44%) had circulating antitopo I ab, vs 10% of the remaining patients (P = 0.001).
DISCUSSION
The present study underlines the high prevalence of ANA in sera from patients with SSc. The nosographical sensitivity of ANA in this study was 86%, which is in accordance with several other studies [2, 3] . The presence of anticentromere ab excluded the presence of other types of ANA investigated in this study. This was also true for antitopo I ab, which by IIF commonly exhibits a very ®ne speckled nucleoplasmic pattern and a speckled nucleolar pattern [10] . The prevalence of anticentromere ab in this patient material was 34% compared with 11± 29% reported previously [2, 4, 6, 14] , which is probably explained by the relatively large proportion of patients in this study with limited involvement (type 1 and 2) and the fact that all patients except one were Caucasians. We do not think that the relatively large number of patients with limited skin involvement is a result of negative selection bias, since the participating centres have responsibility for treating SSc on a national level; severe, diuse cases of SSc in particular. Also, genetic factors may in¯uence the frequency of anticentromere positivity; the presence of the allele DQB1-0501 increases the chance of anticentromere positivity by a factor of three [15, 16] . Our material did not allow analysis of HLA class II genes; however, the prevalence of the allele DQB1-0501 in the general Danish population is 16.7% [17] . This is comparable to the other HLA studies mentioned, which discards this allele as being responsible for the large number of patients with anticentromere ab in this study. However, the high proportion of patients with anticentromere ab may explain the low prevalence of antitopo I ab (14%) compared with the ®ndings in a North American (26%) and an English patient population (21%) [2, 4] . Twenty-seven per cent of the patients in this material who had a homogeneous or ®ne speckled nucleoplasmic pattern did not have detectable antitopo I ab. The immunodiusion technique used for identifying antitopo I ab in this study was also used in the other studies mentioned, but it may not be sensitive enough to detect all antitopo I-positive cases. The prevalence of anti-U1 RNP ab and some subspeci®cities of antinucleolar ab varies with racial factors [6] . The occurrence of anti-U1 RNP, anti-U3 RNP and anti-Th RNP ab found in our study was comparable to the ®ndings in North American Caucasian patients [6] . No patient had anti-U17 RNP ab.
Anticentromere ab mainly identi®ed patients with non-truncal skin involvement, long disease duration, Raynaud's phenomenon, chronic digital ischaemia, s.c. calcinosis and telangiectasia. Oesophageal involvement was not related to anticentromere ab, and pulmonary interstitial ®brosis was related to the absence of anticentromere ab. These clinical relationships have been described earlier [2, 3, 14] . We also found that anticentromere ab were associated with nonrestrictive lung disease aecting pulmonary gas exchange, as reported earlier [3, 18] , probably due to a primary pulmonary vasculopathy. Skeletal muscle involvement was rare (1%) in patients with anticentromere ab. In two other studies, the same tendency was observed [3, 14] . Antimitochondrial ab and anticentromere ab are associated with PBC [3, 19] . In the present study, all of six SSc patients with PBC had circulating anticentromere ab. Of eight patients with sicca complex, six had anticentromere ab; this speci®c relationship has been described previously [5] . Subsequent analysis of the sicca patients showed that none of them had anti-SSA or anti-SSB ab. The presence of PBC or sicca complex did not explain the combination of anticentromere ab and truncal skin involvement seen in 11 patients. These patients did not dier from other anticentromere ab-positive patients with regard to the remaining clinical features.
In the present study, antitopo I ab identi®ed more patients with truncal cutaneous involvement than any other ANA investigated, but the high degree of association described previously [4] was not observed. As previously reported [3, 4] , antitopo I ab were also related to pulmonary interstitial ®brosis by chest radiograph in this study. Distal osteolysis and digital exion contractures were seen more often in patients with than without antitopo I ab. The low frequency of calcinosis in patients with antitopo I ab is explained by the strong relationship between calcinosis and anticentromere ab, and the mutually exclusive occurrence of anticentromere and antitopo I ab.
Thirty-six patients in this study had a nucleolar IIF pattern; the nucleolar speci®cities examined in this study only accounted for 13 of these cases. The rest may be attributable to other antinucleolar speci®cities identi®ed, such as RNA polymerases, PM-Scl, Th40, ®bril-larin, nucleolin, nucleolar organizing region (NOR-90).
No signi®cant clinical associations were found for antinucleolar ab to U3 RNP or Th RNP, except for an inverse relationship between anti-Th RNP ab and SSc joint deformity. Anti-U1 RNP ab identi®ed patients who were young at disease onset and who did not have truncal involvement, as previously found in Japanese patients with SSc [3] . These patients more often had skeletal muscle involvement and polyarthritis than patients without this ab. The core manifestations of mixed connective tissue disease (MCTD) are Raynaud's phenomenon, arthritis, dactylitis and anti-U1-RNP ab [20] . Development of SSc may be uncommon in patients with mixed connective tissue disease [21] , but the dierentiation between the two conditions is often dicult [22] . The presence of anti-U1 RNP ab has also been found related to myositis, arthritis, Raynaud's phenomenon and pulmonary ®brosis in systemic lupus erythematosus [23] , indicating that certain manifestations are to be anticipated in subsets of patients with anti-U1 RNP ab, even though they carry dierent main diagnoses.
